These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18585606)

  • 1. Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
    Migliorati CA; Armonis BN; Nicolatou-Galitis O
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e18-21. PubMed ID: 18585606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
    Tsai WS; Haghighi K; Placa SJ
    Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene.
    Vairaktaris E; Vassiliou S; Avgoustidis D; Stathopoulos P; Toyoshima T; Yapijakis C
    J Oral Maxillofac Surg; 2009 Sep; 67(9):2009-12. PubMed ID: 19686941
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
    Oreadi D; Papageorge MB
    J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801
    [No Abstract]   [Full Text] [Related]  

  • 5. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
    Migliorati CA; Siegel MA; Elting LS
    Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E; Redl P; Márton I
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws.
    Vescovi P; Manfredi M; Merigo E; Meleti M
    J Oral Maxillofac Surg; 2008 Apr; 66(4):831-2. PubMed ID: 18355616
    [No Abstract]   [Full Text] [Related]  

  • 13. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
    Chandra PA; Chandra AB; Todd GK
    Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
    Maksimovic O; Denecke B; Pintoffl JP; Horger M
    Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
    Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
    J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoledronate-related osteonecrosis of the mandible.
    Ho L; Quan V; Henderson R
    Clin Nucl Med; 2008 Jan; 33(1):68-70. PubMed ID: 18097268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA
    Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bisphosphonates and maxillo-mandibular osteo(chemo)necrosis].
    Magremanne M; Vervaet C; Dufrasne L; Declercq I; Legrand W; Daelemans P
    Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):423-8. PubMed ID: 17194993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.